$3.09 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 124 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | New | ABBVIE INC | $89,800,000 | – | 1,534,000 | +100.0% | 2.91% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $48,917,000 | – | 631,192 | +100.0% | 1.58% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $43,424,000 | – | 512,800 | +100.0% | 1.41% | – |
| ZFGN | New | ZAFGEN INC | $41,598,000 | – | 1,050,178 | +100.0% | 1.35% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $33,144,000 | – | 363,700 | +100.0% | 1.07% | – |
| AET | New | AETNA INC NEW | $30,286,000 | – | 284,300 | +100.0% | 0.98% | – |
| XNCR | New | XENCOR INC | $29,040,000 | – | 1,895,535 | +100.0% | 0.94% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $22,950,000 | – | 289,450 | +100.0% | 0.74% | – |
| HUM | New | HUMANA INC | $18,924,000 | – | 106,300 | +100.0% | 0.61% | – |
| NUVA | New | NUVASIVE INC | $15,554,000 | – | 338,194 | +100.0% | 0.50% | – |
| ANTM | New | ANTHEM INC | $15,401,000 | – | 99,742 | +100.0% | 0.50% | – |
| AACH | New | AAC HLDGS INC | $13,649,000 | – | 446,328 | +100.0% | 0.44% | – |
| TXMD | New | THERAPEUTICSMD INC | $13,451,000 | – | 2,223,310 | +100.0% | 0.44% | – |
| STDY | New | STEADYMED LTD | $10,776,000 | – | 1,267,733 | +100.0% | 0.35% | – |
| EXEL | New | EXELIXIS INCput | $10,280,000 | – | 4,000,000 | +100.0% | 0.33% | – |
| GENN | New | GENESIS HEALTHCARE INC | $10,198,000 | – | 1,432,368 | +100.0% | 0.33% | – |
| TNXP | New | TONIX PHARMACEUTICALS HLDG C | $8,627,000 | – | 1,365,000 | +100.0% | 0.28% | – |
| ADHD | New | ALCOBRA LTD | $7,956,000 | – | 1,413,208 | +100.0% | 0.26% | – |
| ELOS | New | SYNERON MEDICAL LTD | $7,745,000 | – | 625,593 | +100.0% | 0.25% | – |
| OXFD | New | OXFORD IMMUNOTEC GLOBAL PLC | $7,353,000 | – | 522,250 | +100.0% | 0.24% | – |
| TCON | New | TRACON PHARMACEUTICALS INC | $6,809,000 | – | 485,000 | +100.0% | 0.22% | – |
| VSAR | New | VERSARTIS INC | $6,240,000 | – | 339,703 | +100.0% | 0.20% | – |
| ZSPH | New | ZS PHARMA INC | $6,202,000 | – | 147,385 | +100.0% | 0.20% | – |
| CLLS | New | CELLECTIS S Asponsored ads | $5,204,000 | – | 150,506 | +100.0% | 0.17% | – |
| New | TRILLIUM THERAPEUTICS INC | $4,573,000 | – | 226,064 | +100.0% | 0.15% | – | |
| CCRN | New | CROSS CTRY HEALTHCARE INC | $4,349,000 | – | 366,724 | +100.0% | 0.14% | – |
| RTRX | New | RETROPHIN INC | $3,791,000 | – | 158,223 | +100.0% | 0.12% | – |
| New | EXELIXIS INCnote 4.250% 8/1 | $3,762,000 | – | 4,985,000 | +100.0% | 0.12% | – | |
| SCMP | New | SUCAMPO PHARMACEUTICALS INCcl a | $3,501,000 | – | 225,000 | +100.0% | 0.11% | – |
| ASND | New | ASCENDIS PHARMA A Ssponsored adr | $3,470,000 | – | 200,000 | +100.0% | 0.11% | – |
| STJ | New | ST JUDE MED INC | $3,294,000 | – | 50,370 | +100.0% | 0.11% | – |
| NVTA | New | INVITAE CORP | $2,793,000 | – | 166,666 | +100.0% | 0.09% | – |
| BVX | New | BOVIE MEDICAL CORP | $1,673,000 | – | 700,000 | +100.0% | 0.05% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $1,610,000 | – | 49,400 | +100.0% | 0.05% | – |
| ALKS | New | ALKERMES PLC | $1,067,000 | – | 17,500 | +100.0% | 0.04% | – |
| New | CORSICANTO LTDnote 3.500% 1/1 | $1,044,000 | – | 1,000,000 | +100.0% | 0.03% | – | |
| MRTX | New | MIRATI THERAPEUTICS INC | $965,000 | – | 32,912 | +100.0% | 0.03% | – |
| ABT | New | ABBOTT LABS | $602,000 | – | 13,000 | +100.0% | 0.02% | – |
| MYL | New | MYLAN N V | $594,000 | – | 10,000 | +100.0% | 0.02% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $502,000 | – | 45,600 | +100.0% | 0.02% | – |
| AEZS | New | AETERNA ZENTARIS INC | $482,000 | – | 898,574 | +100.0% | 0.02% | – |
| RAD | New | RITE AID CORP | $459,000 | – | 52,764 | +100.0% | 0.02% | – |
| MZOR | New | MAZOR ROBOTICS LTDsponsored ads | $470,000 | – | 41,861 | +100.0% | 0.02% | – |
| HMSY | New | HMS HLDGS CORP | $462,000 | – | 29,900 | +100.0% | 0.02% | – |
| CELG | New | CELGENE CORP | $403,000 | – | 3,500 | +100.0% | 0.01% | – |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $232,000 | – | 2,500 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.